Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
NGM831 + Pembrolizumab for Cancer
Recruiting1 awardPhase 1
Oklahoma City, Oklahoma
This trial is testing a new drug, NGM831, as a possible treatment for advanced or metastatic solid tumors.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.